Home Cart Sign in  
Chemical Structure| 220036-08-8 Chemical Structure| 220036-08-8

Structure of NU6027
CAS No.: 220036-08-8

Chemical Structure| 220036-08-8
Product Citations

Alternative Products

Product Details of NU6027

CAS No. :220036-08-8
Formula : C11H17N5O2
M.W : 251.29
SMILES Code : NC1=NC(OCC2CCCCC2)=C(N=O)C(N)=N1
MDL No. :MFCD05664735
InChI Key :DGWXOLHKVGDQLN-UHFFFAOYSA-N
Pubchem ID :398148

Safety of NU6027

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of NU6027

Hedgehog

Isoform Comparison

Biological Activity

Target
  • CDK2

    CDK2, Ki:1.3 μM

  • CDK1

    CDK1, Ki:2.5 μM

In Vitro:

Cell Line
Concentration Treated Time Description References
MCF7 cells 6.7 μM (IC50 ) 24 h NU6027 inhibits ATR activity with an IC50 of 6.7 μM PMC3172902
GM847KD cells 2.8 μM (IC50 ) 24 h NU6027 inhibits ATR activity with an IC50 of 2.8 μM PMC3172902
THP-1 macrophages 25 μM 4 days NU-6027 inhibits growth of M. bovis BCG and M. tuberculosis in macrophages PMC6709498
M. bovis BCG 1.56 μM (IC99 ) 7 days NU-6027 inhibits M. bovis BCG growth in a dose- and time-dependent manner PMC6709498
HEK293 cells 1 μM NU6027 inhibited TRPC5-mediated currents, indicating a direct action on TRPC5 channels. PMC6459797
RAW 264.7 murine macrophages 10 μM 1 hour NU6027 inhibited ATR signaling and prevented TVX-mediated increases in LPS-induced TNF mRNA and protein release PMC4056269
CP70-B1 and CP70-A2 cells 4 μM and 10 μM 24 h NU6027 enhanced temozolomide cytotoxicity, with greater effects in MMR-proficient CP70-B1 cells PMC3172902
A2780 cells 4 μM and 10 μM 24 h NU6027 significantly enhanced cisplatin cytotoxicity, with greater effects in p53 wild-type cells PMC3172902
Mouse cortical neurons 1 μM 24 hours NU6027 significantly reduced H2O2-induced neuronal death, confirmed by LDH release and PI staining. PMC6459797

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Sprague-Dawley rats KA-induced seizure model Intraperitoneal injection 100 μg/kg Single dose, observed for 24 hours NU6027 significantly reduced mortality and neuronal death in KA-induced epileptic rats. PMC6459797
Sprague-Dawley rats Traumatic brain injury (TBI) model Intraperitoneal injection 1 mg/kg Immediately injected once, continued for one week NU6027 reduces TBI-induced neuronal death, zinc accumulation, oxidative stress, and glial activation by inhibiting TRPC5 channels and improves cognitive function PMC7662546
BALB/c mice Tuberculosis infection model Oral 100 mg/kg 5 days a week for 4 weeks NU-6027 inhibits M. tuberculosis growth in Mice tissues PMC6709498

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.98mL

0.80mL

0.40mL

19.90mL

3.98mL

1.99mL

39.79mL

7.96mL

3.98mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories